Literature DB >> 32665413

Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.

Bryan S Stephens1, Tony Ngo1, Irina Kufareva2, Tracy M Handel2.   

Abstract

Because of their prominent roles in development, cancer, and HIV, the chemokine receptor CXCR4 and its ligand CXCL12 have been the subject of numerous structural and functional studies, but the determinants of ligand binding, selectivity, and signaling are still poorly understood. Here, building on our latest structural model, we used a systematic mutagenesis strategy to dissect the functional anatomy of the CXCR4-CXCL12 complex. Key charge swap mutagenesis experiments provided evidence for pairwise interactions between oppositely charged residues in the receptor and chemokine, confirming the accuracy of the predicted orientation of the chemokine relative to the receptor and providing insight into ligand selectivity. Progressive deletion of N-terminal residues revealed an unexpected contribution of the receptor N terminus to chemokine signaling. This finding challenges a longstanding "two-site" hypothesis about the essential features of the receptor-chemokine interaction in which the N terminus contributes only to binding affinity. Our results suggest that although the interaction of the chemokine N terminus with the receptor-binding pocket is the key driver of signaling, the signaling amplitude depends on the extent to which the receptor N terminus binds the chemokine. Together with systematic characterization of other epitopes, these data enable us to propose an experimentally consistent structural model for how CXCL12 binds CXCR4 and initiates signal transmission through the receptor transmembrane domain.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2020        PMID: 32665413      PMCID: PMC7437921          DOI: 10.1126/scisignal.aay5024

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  83 in total

1.  Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.

Authors:  J A Katancik; A Sharma; E de Nardin
Journal:  Cytokine       Date:  2000-10       Impact factor: 3.861

2.  Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.

Authors:  Pasquale Cutolo; Nathalie Basdevant; Guillaume Bernadat; Françoise Bachelerie; Tâp Ha-Duong
Journal:  J Biomol Struct Dyn       Date:  2016-07-11

3.  Structure-Activity Relationship and Signaling of New Chimeric CXCR4 Agonists.

Authors:  Christine E Mona; Élie Besserer-Offroy; Jérôme Cabana; Marilou Lefrançois; Philip E Boulais; Marie-Reine Lefebvre; Richard Leduc; Pierre Lavigne; Nikolaus Heveker; Éric Marsault; Emanuel Escher
Journal:  J Med Chem       Date:  2016-08-11       Impact factor: 7.446

4.  HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Authors:  Y Feng; C C Broder; P E Kennedy; E A Berger
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

5.  GPCR agonist binding revealed by modeling and crystallography.

Authors:  Vsevolod Katritch; Ruben Abagyan
Journal:  Trends Pharmacol Sci       Date:  2011-09-06       Impact factor: 14.819

Review 6.  Pharmacological modulation of chemokine receptor function.

Authors:  D J Scholten; M Canals; D Maussang; L Roumen; M J Smit; M Wijtmans; C de Graaf; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

7.  Mutations in the 'DRY' motif of the CB1 cannabinoid receptor result in biased receptor variants.

Authors:  Pál Gyombolai; András D Tóth; Dániel Tímár; Gábor Turu; László Hunyady
Journal:  J Mol Endocrinol       Date:  2014-12-15       Impact factor: 5.098

8.  Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine.

Authors:  Ling Qin; Irina Kufareva; Lauren G Holden; Chong Wang; Yi Zheng; Chunxia Zhao; Gustavo Fenalti; Huixian Wu; Gye Won Han; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Tracy M Handel
Journal:  Science       Date:  2015-01-22       Impact factor: 47.728

9.  Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis.

Authors:  S Thiele; J Mungalpara; A Steen; M M Rosenkilde; J Våbenø
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

10.  Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.

Authors:  Mette M Rosenkilde; Lars-Ole Gerlach; Sigrid Hatse; Renato T Skerlj; Dominique Schols; Gary J Bridger; Thue W Schwartz
Journal:  J Biol Chem       Date:  2007-06-28       Impact factor: 5.157

View more
  6 in total

1.  The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.

Authors:  Michael J Wedemeyer; Sarah A Mahn; Anthony E Getschman; Kyler S Crawford; Francis C Peterson; Adriano Marchese; John D McCorvy; Brian F Volkman
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

Review 2.  CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy.

Authors:  Rosanna Mezzapelle; Manuela Leo; Francesca Caprioglio; Liam S Colley; Andrea Lamarca; Lina Sabatino; Vittorio Colantuoni; Massimo P Crippa; Marco E Bianchi
Journal:  Cancers (Basel)       Date:  2022-05-06       Impact factor: 6.575

3.  Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists.

Authors:  Pandian Sokkar; Mirja Harms; Christina Stürzel; Andrea Gilg; Gönül Kizilsavas; Martina Raasholm; Nico Preising; Manfred Wagner; Frank Kirchhoff; Ludger Ständker; Gilbert Weidinger; Benjamin Mayer; Jan Münch; Elsa Sanchez-Garcia
Journal:  Commun Biol       Date:  2021-09-22

4.  Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias.

Authors:  Yu-Chen Yen; Christopher T Schafer; Martin Gustavsson; Stefanie A Eberle; Pawel K Dominik; Dawid Deneka; Penglie Zhang; Thomas J Schall; Anthony A Kossiakoff; John J G Tesmer; Tracy M Handel
Journal:  Sci Adv       Date:  2022-07-13       Impact factor: 14.957

5.  A new obligate CXCL4-CXCL12 heterodimer for studying chemokine heterodimer activities and mechanisms.

Authors:  Khanh T P Nguyen; Brian Volkman; Didier Dréau; Irina V Nesmelova
Journal:  Sci Rep       Date:  2022-10-13       Impact factor: 4.996

Review 6.  The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration.

Authors:  Marco E Bianchi; Rosanna Mezzapelle
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.